SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-007726
Filing Date
2023-03-09
Accepted
2023-03-09 16:00:18
Documents
1
Period of Report
2023-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12837
  Complete submission text file 0000899243-23-007726.txt   14148
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVE. LEXINGTON MA 02421
Business Address
Sprague John M (Reporting) CIK: 0001730056 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 23719597